327 related articles for article (PubMed ID: 32729416)
1. Development and Validation of a Five-immune Gene Pair Signature in Endometrial Carcinoma.
Li N; Yu K; Lin Z; Zeng D
Comb Chem High Throughput Screen; 2021; 24(2):233-245. PubMed ID: 32729416
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of a fourteen- innate immunity-related gene pairs signature for predicting prognosis head and neck squamous cell carcinoma.
Zhang F; Liu Y; Yang Y; Yang K
BMC Cancer; 2020 Oct; 20(1):1015. PubMed ID: 33081731
[TBL] [Abstract][Full Text] [Related]
3. Development and Validation of an Individualized Immune Prognostic Signature for Recurrent Prostate Cancer.
Jin Y; Wang L; Lou H; Song C; He X; Ding M
Comb Chem High Throughput Screen; 2021; 24(1):98-108. PubMed ID: 32593277
[TBL] [Abstract][Full Text] [Related]
4. Predicting the clinical outcome of melanoma using an immune-related gene pairs signature.
Meng L; He X; Zhang X; Zhang X; Wei Y; Wu B; Li W; Li J; Xiao Y
PLoS One; 2020; 15(10):e0240331. PubMed ID: 33031392
[TBL] [Abstract][Full Text] [Related]
5. A signature of 18 immune-related gene pairs to predict the prognosis of pancreatic cancer patients.
Bu F; Nie H; Zhu X; Wu T; Lin K; Zhao J; Huang J
Immun Inflamm Dis; 2020 Dec; 8(4):713-726. PubMed ID: 33128857
[TBL] [Abstract][Full Text] [Related]
6. Development of an immune-related gene pairs signature for predicting clinical outcome in lung adenocarcinoma.
Wu C; Hu Q; Ma D
Sci Rep; 2021 Feb; 11(1):3611. PubMed ID: 33574499
[TBL] [Abstract][Full Text] [Related]
7. Identification and Validation of Immune-Related Gene Prognostic Signature for Hepatocellular Carcinoma.
Chen W; Ou M; Tang D; Dai Y; Du W
J Immunol Res; 2020; 2020():5494858. PubMed ID: 32211443
[TBL] [Abstract][Full Text] [Related]
8. Protein-based prognostic signature for predicting the survival and immunotherapeutic efficiency of endometrial carcinoma.
Lai J; Xu T; Yang H
BMC Cancer; 2022 Mar; 22(1):325. PubMed ID: 35337291
[TBL] [Abstract][Full Text] [Related]
9. A signature of immune-related gene pairs (IRGPs) for risk stratification and prognosis of oral cancer patients.
Yu Y; Tian J; Hou Y; Zhang X; Li L; Cong P; Ji L; Wang X
World J Surg Oncol; 2022 Jul; 20(1):227. PubMed ID: 35804390
[TBL] [Abstract][Full Text] [Related]
10. A four-miRNA signature as a novel biomarker for predicting survival in endometrial cancer.
Wu YS; Lin H; Chen D; Yi Z; Zeng B; Jiang Y; Ren G
Gene; 2019 May; 697():86-93. PubMed ID: 30779946
[TBL] [Abstract][Full Text] [Related]
11. An Immune-Related Gene Pairs Signature for Predicting Survival in Glioblastoma.
Wang S; Xu X
Front Oncol; 2021; 11():564960. PubMed ID: 33859933
[No Abstract] [Full Text] [Related]
12. Development and Verification of an Immune-Related Gene Pairs Prognostic Signature in Hepatocellular Carcinoma.
Feng X; Mu S; Ma Y; Wang W
Front Mol Biosci; 2021; 8():715728. PubMed ID: 34660693
[TBL] [Abstract][Full Text] [Related]
13. Identification of hepatocellular carcinoma prognostic markers based on 10-immune gene signature.
Zhao K; Xu L; Li F; Ao J; Jiang G; Shi R; Chen F; Luo Q
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32789471
[TBL] [Abstract][Full Text] [Related]
14. Establishment and validation of a prognostic nomogram based on a novel five-DNA methylation signature for survival in endometrial cancer patients.
Li X; Yin F; Fan Y; Cheng Y; Dong Y; Zhou J; Wang Z; Li X; Wang J
Cancer Med; 2021 Jan; 10(2):693-708. PubMed ID: 33350104
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of an immune-related gene pairs signature in colorectal cancer.
Wu J; Zhao Y; Zhang J; Wu Q; Wang W
Oncoimmunology; 2019; 8(7):1596715. PubMed ID: 31143520
[TBL] [Abstract][Full Text] [Related]
16. Development of immune gene pair-based signature predictive of prognosis and immunotherapy in esophageal cancer.
Cao K; Ma T; Ling X; Liu M; Jiang X; Ma K; Zhu J; Ma J
Ann Transl Med; 2021 Oct; 9(20):1591. PubMed ID: 34790797
[TBL] [Abstract][Full Text] [Related]
17. Discovery and Verification of an Immune-Related Gene Pairs Signature for Predicting Prognosis in Head and Neck Squamous Cell Carcinoma.
He J; Fang X; Han M
Front Genet; 2021; 12():654657. PubMed ID: 34108990
[TBL] [Abstract][Full Text] [Related]
18. Prediction of Survival Outcome in Lower-Grade Glioma Using a Prognostic Signature with 33 Immune-Related Gene Pairs.
Chen S; Sun Y; Zhu X; Mo Z
Int J Gen Med; 2021; 14():8149-8160. PubMed ID: 34803397
[TBL] [Abstract][Full Text] [Related]
19. Establishing a Prognostic Signature Based on Epithelial-Mesenchymal Transition-Related Genes for Endometrial Cancer Patients.
Liu J; Cui G; Shen S; Gao F; Zhu H; Xu Y
Front Immunol; 2021; 12():805883. PubMed ID: 35095892
[TBL] [Abstract][Full Text] [Related]
20. A seven-m6A regulator-related CpG site-based prognostic signature for endometrial carcinoma.
Zhang X; Pang X; Huang Y; Qian S
Medicine (Baltimore); 2021 Jul; 100(29):e26648. PubMed ID: 34398021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
